Cargando…
Liquid biopsy with droplet digital PCR targeted to specific mutations in plasma cell-free tumor DNA can detect ovarian cancer recurrence earlier than CA125
OBJECTIVE: Ovarian cancer (OC) is an intractable gynecological tumor, and frequent recurrence is experienced within a few years even after the complete eradication of tumor tissues by radical resection and neo-adjuvant chemotherapies. The conventional recurrence marker, CA125, is widely used for fol...
Autores principales: | Minato, Takamichi, Ito, Shin, Li, Bin, Fujimori, Haruna, Mochizuki, Mai, Yamaguchi, Kazunori, Tamai, Keiichi, Shimada, Muneaki, Tokunaga, Hideki, Shigeta, Shogo, Sato, Ikuro, Shima, Hiroshi, Yamada, Hidekazu, Yaegashi, Nobuo, Yasuda, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8446792/ https://www.ncbi.nlm.nih.gov/pubmed/34557579 http://dx.doi.org/10.1016/j.gore.2021.100847 |
Ejemplares similares
-
CHD4 regulates platinum sensitivity through MDR1 expression in ovarian cancer: A potential role of CHD4 inhibition as a combination therapy with platinum agents
por: Oyama, Yoshiko, et al.
Publicado: (2021) -
Potential of Tyrosine Kinase Receptor TIE-1 as Novel Therapeutic Target in High-PI3K-Expressing Ovarian Cancer
por: Zhang, Xuewei, et al.
Publicado: (2020) -
A novel 8.57‐kb deletion of the upstream region of PRKAR1A in a family with Carney complex
por: Ito, Shin, et al.
Publicado: (2022) -
Precautions during Direct Oral Anticoagulant Introduction in Gynecologic Malignancies: A Single-Center Retrospective Cohort Study
por: Shimizu, Takanori, et al.
Publicado: (2023) -
Diagnostic Performance of Preoperative Imaging in Endometrial Cancer
por: Hashimoto, Chiaki, et al.
Publicado: (2023)